The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel o ...

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

How are contractors meeting the challenges of designing life sciences buildings that are fit for the future? In south London, ...

The Cambridge Independent Business Awards 2025 are now open for entry. Following the success of our inaugural awards last year, we are delighted to announce that the search is now on for the best in ...

the Cambridge-based firm said in its first-quarter earnings report released yesterday. AstraZeneca previously announced on Feb. 7 that it had received a Notice of Transfer to the Prosecutor and an ...

AstraZeneca Q1 sales rose 7% YoY to $13.59 billion, missing estimates; Earnings per ADS beat at $1.25 vs. $1.11 consensus. Oncology revenue jumped 10% to $5.64 billion; Tagrisso, Imfinzi, and ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to ... Government and the Beijing Economic-Technological Development Area Administrative Office and includes agreements with ...

"The IT, AstraZeneca ... Beyond the opportunity represented by its colleges and office blocks, though, there is also deprivation. Cambridge is considered one of the most unequal cities in the ...

While GSK currently has drug discovery and immunology research teams based out of the CambridgePark office ... footprint in Cambridge, with heavyweights like Takeda and AstraZeneca set to occupy ...